Evidence map›Paper›PMID 35513420›Full record

ReviewNature reviews. Disease primers2022

Achalasia.

Edoardo Savarino, Shobna Bhatia, Sabine Roman, Daniel Sifrim, Jan Tack, Sarah K Thompson, C Prakash Gyawali

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Disease primers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 6 pooled it
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 6 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Standard length of peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2024
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Impact of educational pamphlet in achalasia care: education as therapy among Pakistani patients.Esophagus : official journal of the Japan Esophageal Society · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 7 countries.

Edoardo SavarinoGastroenterology Unit, Azienda Ospedale Università di Padova (AOUP), Padua, Italy. edoardo.savarino@unipd.it.ORCID 0000-0002-3187-2894
Shobna BhatiaDepartment of Gastroenterology, Sir HN Reliance Foundation Hospital, Mumbai, India.ORCID 0000-0001-6132-0356
Sabine RomanHospices Civils de Lyon, Digestive Physiology, Hopital E Herriot, Lyon, France.ORCID 0000-0002-3388-0660
Daniel SifrimWingate Institute of Neurogastroenterology, Queen Mary University of London, London, UK.
Jan TackDivision of Gastroenterology, University Hospital of Leuven, Leuven, Belgium.
Sarah K ThompsonDiscipline of Surgery, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
C Prakash GyawaliDivision of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.
Flinders University · AUKU Leuven · BEQueen Mary University of London · GBSir H.N. Reliance Foundation Hospital and Research Centre · INUniversité Claude Bernard Lyon 1 · FRUniversity of Padua · ITWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achalasia is a rare disorder of the oesophageal smooth muscle characterized by impaired relaxation of the lower oesophageal sphincter (LES) and absent or spastic contractions in the oesophageal body. The key pathophysiological mechanism is loss of inhibitory nerve function that probably results from an autoimmune attack targeting oesophageal myenteric nerves through cell-mediated and, possibly, antibody-mediated mechanisms. Achalasia incidence and prevalence increase with age, but the disorder can affect all ages and both sexes. Cardinal symptoms consist of dysphagia, regurgitation, chest pain and weight loss. Several years can pass between symptom onset and an achalasia diagnosis. Evaluation starts with endoscopy to rule out structural causes, followed by high-resolution manometry and/or barium radiography. Functional lumen imaging probe can provide complementary evidence. Achalasia subtypes have management and prognostic implications. Although symptom questionnaires are not useful for diagnosis, the Eckardt score is a simple symptom scoring scale that helps to quantify symptom response to therapy. Oral pharmacotherapy is not particularly effective. Botulinum toxin injection into the LES can temporize symptoms and function as a bridge to definitive therapy. Pneumatic dilation, per-oral endoscopic myotomy and laparoscopic Heller myotomy can provide durable symptom benefit. End-stage achalasia with a dilated, non-functioning oesophagus may require oesophagectomy or enteral feeding into the stomach. Long-term complications can, rarely, include oesophageal cancer, but surveillance recommendations have not been established.

Indexed as

Esophageal AchalasiaEndoscopyEsophageal Sphincter, LowerFemaleHumansMaleManometryPrognosisTreatment Outcome

Identifiers

PMID35513420
OpenAlexW4229019028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.